نتائج البحث - "Miller, .W.H."

1

مؤتمر

Effectiveness of Simulation-based Learning on Knowledge and Skill Acquisition and Retention among Nursing Students in Riyadh, Saudi Arabia: A Quasi-experimental Study

المؤلفون: Alharbi, A., Mullen, R.F., McClure, J.D., Miller, W.H.

العلاقة: Alharbi, A. , Mullen, R.F. , McClure, J.D. and Miller, W.H. (2024) Effectiveness of Simulation-based Learning on Knowledge and Skill Acquisition and Retention among Nursing Students in Riyadh, Saudi Arabia: A Quasi-experimental Study. RCN Education Conference & Exhibition 2024, York, UK, 22-24 April 2024.

الإتاحة: https://eprints.gla.ac.uk/326451Test/

View record in BASE

2

دورية أكاديمية

537P A phase I/II study of oral chk1 inhibitor LY2880070 in combination with low-dose gemcitabine in patients with advanced or metastatic ovarian cancer

المؤلفون: Miller, W.H., Shields, A.F., Provencher, D., Gilbert, L., Shapiro, G., Oza, A.M., Spratlin, J., Lheureux, S., Bhat, G., Salvador, S., Nunes, P., Lau, S., Weiner, I., Keene, J., Zaknoen, S., Smith, P., Stille, J., Vincett, D., Chu, Q.S-C.

المصدر: Annals of Oncology ; volume 33, page S793-S794 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.665Test
https://api.elsevier.com/content/article/PII:S0923753422025169?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422025169?httpAccept=text/plainTest

View record in BASE

3

دورية أكاديمية

113P Pembrolizumab in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors: An update of the phase II KEYNOTE-158 trial

المؤلفون: Maio, M., Ascierto, P.A., Motola Kuba, D., Penel, N., Cassier, P.A., Bariani, G.M., De Jesus-Acosta, A., Doi, T., Longo Muñoz, F., Miller, W.H., Oh, D-Y., Gottfried, M., Yao, L., Jin, F.J., Gozman, A., Marabelle, A.

المصدر: Annals of Oncology ; volume 33, page S589-S590 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.145Test
https://api.elsevier.com/content/article/PII:S0923753422019962?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422019962?httpAccept=text/plainTest

View record in BASE

4

دورية أكاديمية

362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation

المؤلفون: Desai, J., Han, S-W., Forster, M.D., Kim, T.W., Alonso Casal, G., Shacham Shmueli, E., Bowyer, S.E., De Miguel, M.J., Falcon Gonzalez, A., Jones, R.H., Krebs, M.G., Miller, W.H., Paz-Ares, L., Lorusso, P., Sacher, A., Dharia, N., Lin, M.T., Schutzman, J.L., Shi, Z., Patel, M.

المصدر: Annals of Oncology ; volume 33, page S701-S702 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.500Test
https://api.elsevier.com/content/article/PII:S0923753422023511?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422023511?httpAccept=text/plainTest

View record in BASE

5

دورية أكاديمية

546P Pembrolizumab for microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced endometrial cancer: Long-term follow-up results from KEYNOTE-158

المؤلفون: O'Malley, D., Bariani, G.M., Cassier, P.A., Marabelle, A., Hansen, A.R., De Jesus-Acosta, A., Miller, W.H., Safra, T., Italiano, A., Mileshkin, L., Yao, L., Gozman, A., Jin, F.J., Maio, M.

المصدر: Annals of Oncology ; volume 33, page S796-S797 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.674Test
https://api.elsevier.com/content/article/PII:S092375342202525X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342202525X?httpAccept=text/plainTest

View record in BASE

6

دورية أكاديمية

OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

المصدر: Journal of Thoracic Oncology ; volume 17, issue 9, page S8-S9 ; ISSN 1556-0864

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

الإتاحة: https://doi.org/10.1016/j.jtho.2022.07.023Test
https://api.elsevier.com/content/article/PII:S1556086422003641?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1556086422003641?httpAccept=text/plainTest

View record in BASE

7

دورية أكاديمية

743P A phase Ib dose escalation study of CD137 mAb agonist OC-001 as monotherapy in patients with advanced or metastatic cancer

المؤلفون: Miller, W.H., Provencher, D., Chu, Q.S-C., Jonker, D., Oza, A.M., Batist, G., Jamal, R., Goel, R., Hilton, J.F., Spratlin, J., Smith, P., Darling, I., Stille, J., Fortier, C., Mangat, R., Polzer, J.

المصدر: Annals of Oncology ; volume 33, page S884 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.869Test
https://api.elsevier.com/content/article/PII:S092375342202720X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342202720X?httpAccept=text/plainTest

View record in BASE

8

دورية أكاديمية

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study

المؤلفون: Maio, M., Ascierto, P.A., Manzyuk, L., Motola-Kuba, D., Penel, N., Cassier, P.A., Bariani, G.M., De Jesus Acosta, A., Doi, T., Longo, F., Miller, W.H., Oh, D.-Y., Gottfried, M., Xu, L., Jin, F., Norwood, K., Marabelle, A.

المساهمون: Sanofi, Chugai Pharmaceutical, AbbVie, Daiichi-Sankyo, Meso Scale Diagnostics, Boehringer Ingelheim, Novartis, Merck Sharp and Dohme, AstraZeneca, GlaxoSmithKline, Amgen, Bristol-Myers Squibb, Janssen Pharmaceuticals

المصدر: Annals of Oncology ; volume 33, issue 9, page 929-938 ; ISSN 0923-7534

الإتاحة: https://doi.org/10.1016/j.annonc.2022.05.519Test
https://api.elsevier.com/content/article/PII:S0923753422017203?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422017203?httpAccept=text/plainTest

View record in BASE